---
figid: PMC9696789__ijms-23-13719-g001
pmcid: PMC9696789
image_filename: ijms-23-13719-g001.jpg
figure_link: /pmc/articles/PMC9696789/figure/ijms-23-13719-f001/
number: Figure 1
figure_title: ''
caption: Pharmacokinetic analyses of Apo-LF. (A) Chromatogram of Apo-LF standard in
  testing solution from milk samples; (B) The concentration of Apo-LF in the intestinal
  tissues, stomach tissues and blood of mice after oral gavage; (C) The concentration
  of Apo-LF in the intestinal tissues, stomach tissues and blood of mice after intraperitoneal
  injection.
article_title: Lactoferrin Alleviates Lipopolysaccharide-Induced Infantile Intestinal
  Immune Barrier Damage by Regulating an ELAVL1-Related Signaling Pathway.
citation: Chaonan Li, et al. Int J Mol Sci. 2022 Nov;23(22):13719.
year: '2022'

doi: 10.3390/ijms232213719
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- lactoferrin (LF)
- lipopolysaccharide (LPS)
- intestinal immune barrier damage
- blood immune cells
- ELAVL1

---
